A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer

NCT06776770 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Adebrelimab

Sponsor

Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center